Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Loncar Cancer Immunotherapy ETF

CNCR
Current price
14.25 USD -0.34 USD (-2.32%)
ISIN US26922A8264
Category Healthcare
Exchange NASDAQ
Capitalization 13 111 840 USD
Yield for 12 month +34.26 %
1Y
3Y
5Y
10Y
15Y
CNCR
21.11.2021 - 28.11.2021

Loncar Cancer Immunotherapy ETF, a constituent of the ETF, is listed on the NASDAQ. Its market capitalization stands at 13 111 840 USD. Over the past year, it has generated a yield of +34.26 %. The fund's net expense ratio, a critical measure of operational efficiency, is recorded at 0.79 %. A significant allocation in cash assets underscores its liquidity position and risk management strategy. Turning to technical indicators, they offer a granular perspective on the fund's market behavior, historical trends, and potential forward momentum. For further metrics, refer to www.LoncarFunds.com. For an in-depth analysis get premium access.

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

Total Assets

13 111 840 USD

Net Expense Ratio

0.79 %

Annual Holdings Turnover

86 %

Asset HoldingCNCR

Cash

Long 0.76%
Short 0.08%
Net Assets 0.68%

The US stocks

Long 87.07%
Short -
Net Assets 87.07%

Stocks ex-US

Long 12.25%
Short -
Net Assets 12.25%

Bonds

Long -
Short -
Net Assets -

Other

Long -
Short -
Net Assets -

Efficiency CNCR

1y Volatility 37.96%
Returns YTD 16.70%
3y Volatility 31.94%
Returns 1Y 51.30%
3y ExpReturn 0.00%
Returns 3Y -17.08%
3y SharpRatio -0.61%
Returns 5Y -3.72%
Returns 10Y 0.00%

Dividend Analytics CNCR

Dividend growth over 5 years

Continuous growth

1 year

Dividend History CNCR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Technical indicators CNCR

For 52 weeks

10.3 USD 17.96 USD
50 Day MA 15.05 USD
200 Day MA 15.08 USD